Steger, GG; Bartsch, R; Pfeiler, G; Petru, E; Greil, R; Helfgott, R; Egle, D; Ohler, L; Lang, A; Tinchon, C; Haslbauer, F; Redl, A; Hennebelle, M; Mraz, B; Winiger-Candolfi, I; Gnant, M.
Efficacy and safety of everolimus plus exemestane in HR+, HER2-advanced breast cancer progressing on/after prior endocrine therapy, in routine clinical practice: 2nd interim analysis from STEPAUT
CANCER RES. 2017; 77: -San Antonio Breast Cancer Symposium; DEC 06-10, 2016; San Antonio, TX.
Doi: 10.1158/1538-7445.SABCS16-P4-22-20
[Poster]
Web of Science
FullText
FullText_MUG